| scholarly article | Q13442814 |
| P50 | author | Dennis S. Charney | Q5258920 |
| Wayne C. Drevets | Q36469219 | ||
| Alexander Neumeister | Q43389568 | ||
| Mitchel A. Kling | Q47811908 | ||
| David A Luckenbaugh | Q114238360 | ||
| P2093 | author name string | Husseini K Manji | |
| Roman Duncko | |||
| Alexander Neumeister | |||
| Philip W Gold | |||
| Gyorgy Csako | |||
| Omer Bonne | |||
| Salvatore Alesci | |||
| Rene Costello | |||
| P2860 | cites work | C-reactive protein: a critical update | Q24672855 |
| Serum amyloid A, the major vertebrate acute-phase reactant | Q28145306 | ||
| Acute phase serum amyloid A, cholesterol metabolism, and cardiovascular disease | Q28203617 | ||
| Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey | Q28258215 | ||
| Acute-phase proteins and other systemic responses to inflammation | Q28296941 | ||
| C-reactive protein, inflammation, and coronary risk | Q33843636 | ||
| C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders? | Q34265032 | ||
| Inflammation as a cardiovascular risk factor | Q35789860 | ||
| Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment | Q35796750 | ||
| Is depression a major risk factor for coronary disease? A systematic review of the epidemiologic evidence | Q35809704 | ||
| Inflammation and atherosclerosis in acute coronary syndromes. | Q35849826 | ||
| Thematic review series: The immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? | Q36049902 | ||
| Anti-inflammatory effects of statins: clinical evidence and basic mechanisms | Q36337932 | ||
| Clinical depression and inflammatory risk markers for coronary heart disease | Q37870585 | ||
| Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease | Q37872566 | ||
| Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications | Q40446552 | ||
| Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). | Q40530895 | ||
| C-Reactive protein, serum amyloid A protein, and coronary events | Q44759100 | ||
| Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study | Q44811011 | ||
| Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls | Q45003927 | ||
| Inflammatory markers and sleep disturbance in major depression | Q46439089 | ||
| Sex differences in the relation of body composition to markers of inflammation | Q46580185 | ||
| Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study | Q47657388 | ||
| Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group. | Q50929109 | ||
| Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. | Q51996803 | ||
| A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A. | Q54687423 | ||
| Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression | Q56767480 | ||
| Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition | Q57420160 | ||
| Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy | Q73453199 | ||
| Cytokine production and treatment response in major depressive disorder | Q73505932 | ||
| Is visceral adiposity the "enemy within"? | Q73991356 | ||
| Blood levels of cytokines in elderly patients with major depressive disorder | Q74506108 | ||
| Peroxisome proliferator-activated receptors as therapeutic targets in inflammation | Q79328519 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | major depressive disorder | Q42844 |
| P304 | page(s) | 309-313 | |
| P577 | publication date | 2006-12-18 | |
| P1433 | published in | Biological Psychiatry | Q4914961 |
| P1476 | title | Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A | |
| P478 | volume | 62 |
| Q37623631 | Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy |
| Q37002248 | Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study |
| Q33704099 | Biomarkers for depression: recent insights, current challenges and future prospects |
| Q37323794 | Biomarkers related to aging in human populations. |
| Q36246448 | Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile |
| Q35813088 | Chronic administration of anticonvulsants but not antidepressants impairs bone strength: clinical implications. |
| Q26824899 | Clinical and biochemical manifestations of depression: relation to the neurobiology of stress |
| Q36383540 | Clustering of depression and inflammation in adolescents previously exposed to childhood adversity |
| Q34480323 | Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder |
| Q37884614 | Cytokines and depression: findings, issues, and treatment implications |
| Q36502629 | Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target? |
| Q34071255 | Elevated inflammation levels in depressed adults with a history of childhood maltreatment |
| Q37140192 | Emotion Dysregulation and Inflammation in African-American Women with Type 2 Diabetes. |
| Q44613025 | Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approach |
| Q48434688 | Evidence that stress per se has a role in the precipitation and natural history of depressive illness |
| Q36064163 | Genetic biomarkers of depression |
| Q37359240 | HIV infection and drugs of abuse: role of acute phase proteins |
| Q38021672 | Heartache and heartbreak--the link between depression and cardiovascular disease |
| Q37860257 | Hormones, heart disease, and health: individualized medicine versus throwing the baby out with the bathwater |
| Q43872474 | Hormones, heart disease, and health: individualized medicine versus throwing the baby out with the bathwater |
| Q88360239 | How Are Ocular Signs and Symptoms of Dry Eye Associated With Depression in Women With and Without Sjögren Syndrome? |
| Q51892229 | Identifying blood biomarkers for mood disorders using convergent functional genomics. |
| Q34511208 | Immune suppression and immune activation in depression |
| Q28288750 | Inflammatory biomarkers and depression |
| Q89955784 | Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls |
| Q36762362 | Marriage protects men from clinically meaningful elevations in C-reactive protein: results from the National Social Life, Health, and Aging Project (NSHAP). |
| Q37414767 | Membrane omega-3 Fatty Acid deficiency as a preventable risk factor for comorbid coronary heart disease in major depressive disorder |
| Q36391143 | Mitigation of Inflammation-Induced Mood Dysregulation by Long-Chain Omega-3 Fatty Acids |
| Q57285359 | Neuroimmunomodulation in Major Depressive Disorder: Focus on Caspase 1, Inducible Nitric Oxide Synthase, and Interferon-Gamma |
| Q38226495 | Neuroimmunomodulation in depression: a review of inflammatory cytokines involved in this process |
| Q34361528 | Omega-3 fatty acid deficiency increases constitutive pro-inflammatory cytokine production in rats: Relationship with central serotonin turnover |
| Q38062782 | Pathological parainflammation and endoplasmic reticulum stress in depression: potential translational targets through the CNS insulin, klotho and PPAR-γ systems |
| Q37435408 | Plasma CRP levels in premenopausal women with major depression: a 12-month controlled study |
| Q36938136 | Prepartum Depressive Symptoms Correlate Positively with C-Reactive Protein Levels and Negatively with Tryptophan Levels: A Preliminary Report |
| Q93144459 | Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels |
| Q36235932 | Psychological and social resources relate to biomarkers of allostasis in newly admitted nursing home residents |
| Q35554351 | Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder |
| Q57134994 | Replication and reproducibility issues in the relationship between C-reactive protein and depression: A systematic review and focused meta-analysis |
| Q37276319 | Synergistic relationships among stress, depression, and troubled relationships: insights from psychoneuroimmunology |
| Q47985529 | The Biomarkers Consortium: on the critical path of drug discovery |
| Q47757975 | The acute-phase mediator serum amyloid A is associated with symptoms of depression and fatigue. |
| Q48143702 | The adapter proteins of TLRs, TRIF and MYD88, are upregulated in depressed individuals |
| Q38285276 | The organization of the stress system and its dysregulation in depressive illness |
Search more.